These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33968830)

  • 1. Atezolizumab-induced encephalitis in a patient with metastatic breast cancer: a case report and review of neurological adverse events associated with checkpoint inhibitors.
    Nader R; Tannoury E; Rizk T; Ghanem H
    Autops Case Rep; 2021 Apr; 11():e2021261. PubMed ID: 33968830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atezolizumab-related encephalitis in the intensive care unit: Case report and review of the literature.
    Laserna A; Tummala S; Patel N; El Hamouda DEM; Gutiérrez C
    SAGE Open Med Case Rep; 2018; 6():2050313X18792422. PubMed ID: 30116528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atezolizumab-associated encephalitis in metastatic lung adenocarcinoma: a case report.
    Yamaguchi Y; Nagasawa H; Katagiri Y; Wada M
    J Med Case Rep; 2020 Jul; 14(1):88. PubMed ID: 32620173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atezolizumab-associated encephalitis in metastatic breast cancer: A case report.
    Chen G; Zhang C; Lan J; Lou Z; Zhang H; Zhao Y
    Oncol Lett; 2022 Sep; 24(3):324. PubMed ID: 35949609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atezolizumab-induced cerebellar ataxia in a patient with metastatic small cell lung cancer: A case report and literature review.
    Kapagan T; Aksu F; Yuzkan S; Bulut N; Erdem GU
    J Oncol Pharm Pract; 2024 Jan; 30(1):201-205. PubMed ID: 37321205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atezolizumab-induced encephalitis with subdural hemorrhage and subarachnoid hemorrhage in a patient with hepatocellular carcinoma.
    Chao KH; Tseng TC
    J Formos Med Assoc; 2023 Nov; 122(11):1208-1212. PubMed ID: 37567840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excellent Response to Atezolizumab After Clinically Defined Hyperprogression Upon Previous Treatment With Pembrolizumab in Metastatic Triple-Negative Breast Cancer: A Case Report and Review of the Literature.
    Feng D; Guan Y; Liu M; He S; Zhao W; Yin B; Liang J; Li Y; Wang J
    Front Immunol; 2021; 12():608292. PubMed ID: 34135884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atezolizumab and bevacizumab-induced encephalitis in advanced hepatocellular carcinoma: Case report and literature review.
    Özdirik B; Jost-Brinkmann F; Savic LJ; Mohr R; Tacke F; Ploner CJ; Roderburg C; Müller T
    Medicine (Baltimore); 2021 Jun; 100(24):e26377. PubMed ID: 34128898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atezolizumab-induced Autoimmune Diabetes in a Patient with Metastatic Breast Cancer: A Case Report.
    Clontz R; Dang DM; Hieger MA; Becker BA
    Clin Pract Cases Emerg Med; 2021 May; 5(2):190-193. PubMed ID: 34437002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hope, Cure, and Adverse Effects in Immunotherapy: Atezolizumab-Associated Encephalitis in Metastatic Small Cell Lung Cancer - A Case Report and Literature Review.
    Ibrahim EY; Zhao WC; Mopuru H; Janowiecki C; Regelmann DJ
    Case Rep Neurol; 2022; 14(3):366-371. PubMed ID: 36824581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atezolizumab-induced Encephalitis in a Patient with Hepatocellular Carcinoma: A Case Report and Literature Review.
    Satake T; Maruki Y; Kubo Y; Takahashi M; Ohba A; Nagashio Y; Kondo S; Hijioka S; Morizane C; Ueno H; Okusaka T
    Intern Med; 2022 Sep; 61(17):2619-2623. PubMed ID: 35185051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune checkpoint inhibitor-induced aseptic meningitis and encephalitis: a case-series and narrative review.
    Thouvenin L; Olivier T; Banna G; Addeo A; Friedlaender A
    Ther Adv Drug Saf; 2021; 12():20420986211004745. PubMed ID: 33854755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world safety experience with immune checkpoint inhibitors in Saudi Arabia.
    Al Nuhait M; Bajnaid E; Al Otaibi A; Al Shammari A; Al Awlah Y
    Sci Prog; 2021; 104(1):36850421997302. PubMed ID: 33689534
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune Checkpoint Inhibitor-Induced Limbic Encephalitis during Treatment with Atezolizumab in a Patient with Small-Cell Lung Cancer: A Case Report and Review of the Literature.
    Nakashima K; Demura Y; Kurokawa K; Takeda T; Jikuya N; Oi M; Tada T; Akai M; Ishizuka T
    Case Reports Immunol; 2022; 2022():9290922. PubMed ID: 35036012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atezolizumab-Induced Aseptic Meningitis in Patients with NSCLC.
    Toyozawa R; Haratake N; Toyokawa G; Matsubara T; Takamori S; Miura N; Yamaguchi M; Takenoyama M; Seto T
    JTO Clin Res Rep; 2020 Mar; 1(1):100012. PubMed ID: 34589914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encephalitis in a Patient With Melanoma Treated With Immune Checkpoint Inhibitors: Case Presentation and Review of the Literature.
    Gkoufa A; Gogas H; Diamantopoulos PT; Ziogas DC; Psichogiou M
    J Immunother; 2020 Sep; 43(7):224-229. PubMed ID: 32554976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atezolizumab-associated myositis in a patient with unresectable hepatocellular carcinoma.
    Baigi T; Brown EN; De La Torre RM; Abu-Shahin FI
    J Oncol Pharm Pract; 2023 Oct; 29(7):1757-1761. PubMed ID: 37282559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atezolizumab-Induced Acrodermatitis and Pustular Psoriasis in a Patient with Non-Small Cell Lung Cancer: A Rare Case Report.
    Fattore D; Esposito G; Carangelo L; Luciano MA; Megna M
    Case Rep Dermatol; 2024; 16(1):42-46. PubMed ID: 38384677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial.
    Schmid P; Rugo HS; Adams S; Schneeweiss A; Barrios CH; Iwata H; Diéras V; Henschel V; Molinero L; Chui SY; Maiya V; Husain A; Winer EP; Loi S; Emens LA;
    Lancet Oncol; 2020 Jan; 21(1):44-59. PubMed ID: 31786121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor immune microenvironment and genomic evolution in a patient with metastatic triple negative breast cancer and a complete response to atezolizumab.
    Molinero L; Li Y; Chang CW; Maund S; Berg M; Harrison J; Fassò M; O'Hear C; Hegde P; Emens LA
    J Immunother Cancer; 2019 Oct; 7(1):274. PubMed ID: 31647026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.